Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

by Matthieu Roulleaux Dugage, Robin Lewis Jones, Jonathan Trent, Stéphane Champiat, Sarah Dumont
Published 2021-08-01

Systematic review of phase‐I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the research

by Arthur Felix, Pablo Berlanga, Maud Toulmonde, Judith Landman‐Parker, Sarah Dumont, Gilles Vassal, Marie‐Cécile Le Deley, Nathalie Gaspar
Published 2021-03-01

Working to improve the management of sarcoma patients across Europe: a policy checklist

by Bernd Kasper, Estelle Lecointe-Artzner, Suzanne Wait, Shannon Boldon, Roger Wilson, Alessandro Gronchi, Claudia Valverde, Mikael Eriksson, Sarah Dumont, Nora Drove, Athanasia Kanli, Markus Wartenberg
Published 2018-04-01

Outcomes of patients with metastatic gastrointestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib as first-line treatment

by Etienne Rouleau, Axel Le Cesne, Olivier Mir, Pierre Méeus, Julien Adam, Alice Boilève, Armelle Dufresne, Ali Chamseddine, Elise Nassif, Sarah Dumont, Medhi Brahmi, Marie Karanian, Véronique Haddad, Matthieu Faron, Charles Honoré
Published 2020-12-01

Prospective evaluation of intensity-modulated radiotherapy toxicity in extremity soft tissue sarcomas patients: A role for irradiated healthy soft tissue volume?

by Rémi Bourdais, Samir Achkar, Charles Honoré, Matthieu Faron, Andrea Cavalcanti, Guillaume Auzac, Carine Ngo, Leila Haddag-Miliani, Benjamin Verret, Sarah Dumont, Eric Deutsch, Axel Le Cesne, Olivier Mir, Cécile Le Péchoux, Antonin Levy
Published 2021-07-01

Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab

by Samy Ammari, Raoul Sallé de Chou, Tarek Assi, Mehdi Touat, Emilie Chouzenoux, Arnaud Quillent, Elaine Limkin, Laurent Dercle, Joya Hadchiti, Mickael Elhaik, Salma Moalla, Mohamed Khettab, Corinne Balleyguier, Nathalie Lassau, Sarah Dumont, Cristina Smolenschi
Published 2021-07-01

<i>TP53</i> Mutation as a Prognostic and Predictive Marker in Sarcoma: Pooled Analysis of MOSCATO and ProfiLER Precision Medicine Trials

by Elise F. Nassif, Edouard Auclin, Rastilav Bahleda, Charles Honoré, Olivier Mir, Sarah Dumont, Benoite Mery, Khalil Hodroj, Mehdi Brahmi, Olivier Trédan, Isabelle Ray-Coquard, Jean-Yves Blay, Christophe Massard, Axel Le Cesne, Armelle Dufresne
Published 2021-07-01

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of Frenc...

by Stefano Kim, Marine Jary, Thierry André, Véronique Vendrely, Bruno Buecher, Eric François, François-Clément Bidard, Sarah Dumont, Emmanuelle Samalin, Didier Peiffert, Simon Pernot, Nabil Baba-Hamed, Farid El Hajbi, Olivier Bouché, Jérôme Desrame, Aurélie Parzy, Mustapha Zoubir, Christophe Louvet, Jean-Baptiste Bachet, Thierry Nguyen, Meher Ben Abdelghani, Denis Smith, Christelle De La Fouchardière, Thomas Aparicio, Jaafar Bennouna, Jean-Marc Gornet, Marion Jacquin, Franck Bonnetain, Christophe Borg
Published 2017-08-01